1. Home
  2. AMRN
  3. AMRN News

Latest Amarin Corporation plc (AMRN) News on May 10, 2025

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y
AMRN

Zacks

a day ago

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y

Amarin First Quarter 2025 Earnings: Misses Expectations
AMRN

Simply Wall St.

2 days ago

Amarin First Quarter 2025 Earnings: Misses Expectations

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...
AMRN

GuruFocus.com

2 days ago

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...

AMRN

Associated Press Finance

3 days ago

Amarin: Q1 Earnings Snapshot

Amarin Reports First Quarter 2025 Financial Results
AMRN

GlobeNewswire

3 days ago

Amarin Reports First Quarter 2025 Financial Results

AMRN

GuruFocus.com

7 days ago

Standex International Corp (SXI) Q3 2025 Earnings Call Highlights: Record Margins and Strategic ...

Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
AMRN

GlobeNewswire

10 days ago

Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
AMRN

GlobeNewswire

11 days ago

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
AMRN

GlobeNewswire

a month ago

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
AMRN

GlobeNewswire

a month ago

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors

Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
AMRN

GlobeNewswire

a month ago

Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist

AMRN

MT Newswires

2 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

AMRN

MT Newswires

2 months ago

Amarin Shareholders Calls for Strategic Review

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
AMRN

GlobeNewswire

2 months ago

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
AMRN

Zacks

2 months ago

AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ...
AMRN

GuruFocus.com

2 months ago

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ...

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript
AMRN

Motley Fool

2 months ago

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript

AMRN

MT Newswires

2 months ago

Amarin Plans 1-for-20 ADS Ratio Adjustment

AMRN

Associated Press Finance

2 months ago

Amarin: Q4 Earnings Snapshot

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program
AMRN

GlobeNewswire

2 months ago

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program

Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action
AMRN

GlobeNewswire

2 months ago

Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering
AMRN

GlobeNewswire

2 months ago

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering

Amarin Receives National Reimbursement for VAZKEPA® in Austria
AMRN

GlobeNewswire

2 months ago

Amarin Receives National Reimbursement for VAZKEPA® in Austria

Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation
AMRN

Simply Wall St.

2 months ago

Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025
AMRN

GlobeNewswire

3 months ago

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025

Amarin Receives National Reimbursement for VAZKEPA® in Italy
AMRN

GlobeNewswire

5 months ago

Amarin Receives National Reimbursement for VAZKEPA® in Italy

AMRN

MT Newswires

5 months ago

Amarin Names Peter Fishman as CFO

Amarin Appoints Peter Fishman Chief Financial Officer
AMRN

GlobeNewswire

5 months ago

Amarin Appoints Peter Fishman Chief Financial Officer

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
AMRN

Zacks

6 months ago

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)

Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions
AMRN

GlobeNewswire

6 months ago

Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions

Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...
AMRN

GuruFocus.com

6 months ago

Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...

Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
AMRN

Zacks

6 months ago

Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript
AMRN

Motley Fool

6 months ago

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript

AMRN

Associated Press Finance

6 months ago

Amarin: Q3 Earnings Snapshot

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update
AMRN

GlobeNewswire

6 months ago

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update

Amarin Corp PLC (AMRN) Q3 2024 Earnings Report Preview: What To Look For
AMRN

GuruFocus.com

6 months ago

Amarin Corp PLC (AMRN) Q3 2024 Earnings Report Preview: What To Look For

Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
AMRN

GuruFocus.com

7 months ago

Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

AMRN

MT Newswires

7 months ago

Opthea Names Medical Chief, CFO

Amarin Announces Two Upcoming Investor Events
AMRN

GlobeNewswire

7 months ago

Amarin Announces Two Upcoming Investor Events

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation
AMRN

Simply Wall St.

8 months ago

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation

Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting
AMRN

GlobeNewswire

8 months ago

Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress
AMRN

GlobeNewswire

9 months ago

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress

Exploring 3 Undervalued Small Caps In United States With Insider Action
AMRN

Simply Wall St.

9 months ago

Exploring 3 Undervalued Small Caps In United States With Insider Action

Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat
AMRN

Zacks

9 months ago

Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat

Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
AMRN

Motley Fool

9 months ago

Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update
AMRN

GlobeNewswire

9 months ago

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
AMRN

Zacks

10 months ago

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?

Amarin Corporation plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price
AMRN

Simply Wall St.

10 months ago

Amarin Corporation plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price

AMRN

MT Newswires

10 months ago

Sector Update: Health Care Stocks Edge Lower Premarket Thursday

AMRN

MT Newswires

10 months ago

Amarin Says Vazkepa Secures National Reimbursement in Portugal

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal
AMRN

GlobeNewswire

10 months ago

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal

Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024
AMRN

GlobeNewswire

10 months ago

Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024

AMRN

MT Newswires

10 months ago

Amarin Commercial Partner in China Receives Regulatory Approval for Heart Drug Vascepa

Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)
AMRN

GlobeNewswire

10 months ago

Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)

AMRN

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Tuesday Afternoon

AMRN

MT Newswires

a year ago

Sector Update: Health Care

AMRN

MT Newswires

a year ago

Update: Amarin Shares Fall After CEO Resignation

AMRN

MT Newswires

a year ago

Amarin Names Aaron Berg as Chief Executive Officer

Amarin Board of Directors Announces CEO Transition
AMRN

GlobeNewswire

a year ago

Amarin Board of Directors Announces CEO Transition

AMRN

MT Newswires

a year ago

Amarin Says Greece Approves Vazkepa for National Reimbursement; Signs Commercialization Agreement With Vianex

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.
AMRN

GlobeNewswire

a year ago

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
AMRN

GlobeNewswire

a year ago

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript
AMRN

Insider Monkey

a year ago

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
AMRN

Zacks

a year ago

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Amarin First Quarter 2024 Earnings: EPS Beats Expectations
AMRN

Simply Wall St.

a year ago

Amarin First Quarter 2024 Earnings: EPS Beats Expectations

Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
AMRN

Zacks

a year ago

Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
AMRN

Motley Fool

a year ago

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript

Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focus
AMRN

GuruFocus.com

a year ago

Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focus

AMRN

Associated Press Finance

a year ago

Amarin: Q1 Earnings Snapshot

Amarin Reports First Quarter 2024 Business Update and Financial Results
AMRN

GlobeNewswire

a year ago

Amarin Reports First Quarter 2024 Business Update and Financial Results

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
AMRN

GlobeNewswire

a year ago

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

Amarin Announces Results of Annual General Meeting of Shareholders
AMRN

GlobeNewswire

a year ago

Amarin Announces Results of Annual General Meeting of Shareholders

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
AMRN

GlobeNewswire

a year ago

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
AMRN

GlobeNewswire

a year ago

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
AMRN

CNW Group

a year ago

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
AMRN

GlobeNewswire

a year ago

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
AMRN

Zacks

a year ago

Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe

Why Amarin Stock Was Rocketing Higher on Wednesday
AMRN

Motley Fool

a year ago

Why Amarin Stock Was Rocketing Higher on Wednesday

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
AMRN

GlobeNewswire

a year ago

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
AMRN

GlobeNewswire

a year ago

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

Amarin Full Year 2023 Earnings: Beats Expectations
AMRN

Simply Wall St.

a year ago

Amarin Full Year 2023 Earnings: Beats Expectations

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecasts
AMRN

Simply Wall St.

a year ago

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecasts

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
AMRN

Zacks

a year ago

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates

Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript
AMRN

Insider Monkey

a year ago

Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript

Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript
AMRN

Motley Fool

a year ago

Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript

AMRN

Associated Press Finance

a year ago

Amarin: Q4 Earnings Snapshot

Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition
AMRN

GuruFocus.com

a year ago

Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AMRN

GlobeNewswire

a year ago

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
AMRN

GlobeNewswire

a year ago

Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024

5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
AMRN

Zacks

a year ago

5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates

Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists
AMRN

Motley Fool

a year ago

Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists

Invesco Closed-End Funds Declare Dividends
AMRN

PR Newswire

a year ago

Invesco Closed-End Funds Declare Dividends

Republic Bancorp (NASDAQ:RBCA.A) Has Announced That It Will Be Increasing Its Dividend To $0.407
AMRN

Simply Wall St.

a year ago

Republic Bancorp (NASDAQ:RBCA.A) Has Announced That It Will Be Increasing Its Dividend To $0.407

2 Magnificent Stocks to Buy That Are Near 52-Week Lows
AMRN

Motley Fool

a year ago

2 Magnificent Stocks to Buy That Are Near 52-Week Lows

AMRN

Thomson Reuters StreetEvents

a year ago

Q4 2023 Hilltop Holdings Inc Earnings Call

Shuffle Board: Designer Brands Names President, Kirkland’s Taps Amy Sullivan as CEO
AMRN

Sourcing Journal

a year ago

Shuffle Board: Designer Brands Names President, Kirkland’s Taps Amy Sullivan as CEO

Hilltop Holdings Inc.'s (NYSE:HTH) high institutional ownership speaks for itself as stock continues to impress, up 4.0% over last week
AMRN

Simply Wall St.

a year ago

Hilltop Holdings Inc.'s (NYSE:HTH) high institutional ownership speaks for itself as stock continues to impress, up 4.0% over last week

AMRN

Reuters

a year ago

UPDATE 1-Europe to withdraw PTC Therapeutics' rare muscle disorder drug

AMRN

Reuters

a year ago

PTC Therapeutics' muscle disorder drug fails to secure EU regulator backing

Ocular Therapeutix™ Announces FDA Agreement to Amend Special Protocol Assessment (SPA) for Pivotal Clinical Trial of AXPAXLI™ in Wet AMD
AMRN

GlobeNewswire

a year ago

Ocular Therapeutix™ Announces FDA Agreement to Amend Special Protocol Assessment (SPA) for Pivotal Clinical Trial of AXPAXLI™ in Wet AMD

Share on Social Networks: